Diversion Quarterly Report, Q2 2026

Protecting your patients and staff starts with a complete view of medication workflows. The Diversion Quarterly Report, Q2 2026 breaks down new data from nearly 1,900 healthcare sites tracking over 32 million controlled substances.

See where documentation mistakes are causing 47% of routine variances, which high-risk drugs need the closest eye, and how tools like Prism Assistant can reduce investigation times by up to 97%.

Download the full report now to benchmark your facility, strengthen compliance, and stop diversion risks.